NCT02474212View on ClinicalTrials.gov

: Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

85

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

March 31, 2023

Study Completion Date

March 31, 2023

Conditions
Venous ThromboembolismPulmonary EmbolismThromboprophylaxis
Interventions
DRUG

Enoxaparin

Trial Locations (1)

33521

Tampere University Hospital, Tampere

All Listed Sponsors
collaborator

Heart Hospital, Tampere University Hospital

UNKNOWN

lead

Tampere University Hospital

OTHER

NCT02474212 - : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery | Biotech Hunter | Biotech Hunter